Bristol-Myers Squibb (BMY) Announces Late-Breaking Data at EULAR 2022 Demonstrate Deucravacitinib Significantly Improved Disease Activity in Phase 2 PAISLEY Study in Systemic Lupus Erythematosus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Nasdaq, S&P 500 slip from record highs as yields and oil rebound
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 59.67 +0.08 (0.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.59 | 52 Week High | $77.12 | |||
| Open | $59.45 | 52 Week Low | $49.03 | |||
| Day High | $59.71 | P/E | 38.75 | |||
| Day Low | $59.01 | EPS | $1.54 | |||
| Volume | 1,357,413 | |||||
